Hypophosphatasia (HPP) (DBCOND0041425)

Identifiers

Synonyms
Hypophosphatasia / Other disorders of phosphorus metabolism / Deficiency of alkaline phosphatase (disorder) / Hypophosphatasia (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04181164
Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP)No drug interventionsNot AvailableNot Availableunknown_status
NCT00952484
Safety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)treatment2completed
NCT02104219
Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)No drug interventionsNot AvailableNot Availablecompleted
NCT02306720
Registry of Patients With HypophosphatasiaNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT00739505
Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)treatment1completed
NCT01419028
A Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia (HPP)No drug interventionsNot AvailableNot Availablecompleted
NCT00744042
Safety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)treatment1 / 2completed
NCT01203826
Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)treatment2completed
NCT06079281
Phase 3 Study of ALXN1850 Versus Placebo in Adolescent and Adult Participants With HPP Who Have Not Previously Been Treated With Asfotase AlfaNo drug interventionstreatment3recruiting
NCT06079359
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPPNo drug interventionstreatment3recruiting
NCT06079372
Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfatreatment3recruiting
NCT06015750
Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasiatreatment4not_yet_recruiting
NCT02797821
Pharmacokinetic and Dose Response Study of Asfotase Alfa in Adult Patients With Pediatric-Onset Hypophosphatasia (HPP)treatment2completed
NCT02796885
Characterisation of Adult-Onset HypophosphatasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT04189315
Relieving Burden of Hypophosphatasia in Adults With Functional Impairment Due to Chronic Diseasetreatment4withdrawn
NCT00894075
Safety and Efficacy Study of ENB-0040 in Juvenile Patients With Hypophosphatasia (HPP)treatment2withdrawn
NCT06161142
Characteristics of Hypophosphatasia in Adult Patients in RheumatologyNo drug interventionsNot AvailableNot Availablerecruiting
NCT04195763
Patient Reported Outcomes in Adults With Pediatric-onset Hypophosphatasia Treated With Strensiq® (Asfotase Alfa)Not AvailableNot Availablecompleted
NCT05596539
Prospective, Longitudinal, Observational Registry of Adult Patients With Hypophosphatasia (REG-HYPO)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04980248
Study of ALXN1850 in Participants With Hypophosphatasia (HPP)No drug interventionsbasic_science1completed
NCT06574282
Characteristics of Hypophosphatasia in Adult Patients in Rheumatology and Their Value in Developing an Algorithm to HPP-diagnosis - the COHIR Multi-center StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT05062629
United States Hypophosphatasia Molecular Research CenterNo drug interventionsNot AvailableNot Availablerecruiting
NCT02496689
Expanded Access Program for Asfotase Alfa Treatment for Patients With Infantile- or Juvenile-onset Hypophosphatasia (HPP)Not AvailableNot Availableapproved_for_marketing
NCT03418389
Evaluate and Monitor Physical Performance of Adults Treated With Asfotase Alfa for HypophosphatasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT05234567
A Prospective Sub-Study of the Global Hypophosphatasia RegistryNot AvailableNot Availablerecruiting
NCT03655223
Early Check: Expanded Screening in NewbornsNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02456038
Safety and Efficacy of Asfotase Alfa in Patients With Hypophosphatasia (HPP)treatment2completed
NCT04018287
Circulating miRNAs and Bone Microstructure in Adults With HypophosphatasiaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT01406977
Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)treatment2completed
NCT02291497
Burden of Disease in Hypophosphatasia (HPP)No drug interventionsNot AvailableNot Availablecompleted
NCT02235493
Non-interventional Substudy of ALX-HPP-502 to Assess Natural History of Patients With Juvenile-onset HPP Who Served as Historical Controls in ENB-006-09No drug interventionsNot AvailableNot Availablecompleted
NCT04222452
The PORTRAIT StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01205152
Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP)treatment2completed
NCT01163149
Safety and Efficacy Study of Asfotase Alfa in Adolescents and Adults With Hypophosphatasia (HPP)treatment2completed
NCT02237625
Natural History Study of Patients With Hypophosphatasia (HPP)No drug interventionsNot AvailableNot Availablerecruiting
NCT01176266
Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)treatment2 / 3completed
NCT05890794
Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasiatreatment1 / 2completed
NCT02531867
Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japantreatment4completed
NCT02751801
Health Burden of HypophosphatasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT04925804
Unraveling Genetics of HypoPhosPhatasia (HPP Genetics)No drug interventionsNot AvailableNot Availablecompleted
NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordNo drug interventionsNot AvailableNot Availablerecruiting